Healthcare Group Sanofi to Buy Origimm Biotechnology to Boost Vaccines Business

PARIS — French healthcare company Sanofi has agreed to buy Austrian group Origimm Biotechnology in a move that Sanofi said would boost its vaccines business. Read More